Clinical Trial Update: Ketamine and Postoperative Cognitive Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ketamine for postoperative cognitive dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cognitive Dysfunction

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Post Operative Cognitive Dysfunction | Phase 3 | Status: COMPLETED